- Market Capitalization, $K 4,305,245
- Shares Outstanding, K 316,795
- Annual Sales, $ 405,770 K
- Annual Income, $ -63,200 K
- 60-Month Beta 2.54
- Price/Sales 11.10
- Price/Cash Flow 190.68
- Price/Book 3.83
|Period||Period Low||Period High||Performance|
| || |
-6.42 (-31.75%)since 03/16/21
| || |
+1.38 (+11.11%)since 01/15/21
| || |
+10.23 (+286.55%)since 04/16/20
Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that the Tilray board of directors approved an amendment to the Company's...
, /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (TSXV: HITI) (OTCQB: HITIF) (FRA:2LY), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption...
The Global Cannabis Market is projected to reach USD 48.29 billion in 2027. The market is being predominantly driven by the growing usage of cannabis for many medicinal and recreational usage and increasing...
Aphria Inc.'s Adult-Use Brands Good Supply and Solei Introduce High Potency Oils to its Product Lineup
, /PRNewswire/ - Aphria Inc. ("") (TSX: APHA) (NASDAQ: APHA), a leading global cannabis-lifestyle consumer packaged goods company, today announced that its holders (the "") of Aphria's common shares...
Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that the special meeting of Tilray stockholders (the "Tilray Special Meeting")...
Kenneth Research recently added a report on 'Medical Cannabis Market' in its database of market research reports which provides its readers an in-depth analysis on the latest trends, growth opportunities...
, /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (TSXV: HITI) (OTCQB: HITIF) (: 2LY), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption...
, /PRNewswire/ -- The medical cannabis market has made some remarkable accomplishments in the past few years with the launch of innovative products. The clinical trials and approval of some cannabis-infused...
|3rd Resistance Point||15.60|
|2nd Resistance Point||15.14|
|1st Resistance Point||14.36|
|1st Support Level||13.13|
|2nd Support Level||12.68|
|3rd Support Level||11.90|